| scholarly article | Q13442814 |
| P50 | author | Andy Borman | Q67488441 |
| P2093 | author name string | Elizabeth M Johnson | |
| Adrien Szekely | |||
| P2860 | cites work | Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. | Q30585360 |
| Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
| Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. | Q33609053 | ||
| Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii | Q34196084 | ||
| First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
| New clonal strain of Candida auris, Delhi, India | Q34372060 | ||
| Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek | Q35586995 | ||
| Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database | Q35847935 | ||
| Invasive Candida infections: the changing epidemiology. | Q36025508 | ||
| Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry | Q36049838 | ||
| Emerging fungal diseases | Q36199785 | ||
| Echinocandin resistance in two Candida haemulonii isolates from pediatric patients | Q36362961 | ||
| Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts | Q36447065 | ||
| Comparative Genomics and the Evolution of Pathogenicity in Human Pathogenic Fungi | Q37809416 | ||
| Multidrug-resistant endemic clonal strain of Candida auris in India. | Q39092162 | ||
| Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis | Q39092224 | ||
| Nosocomial Candida. Epidemiology, transmission, and prevention | Q41502762 | ||
| Development of an insect model for the in vivo pathogenicity testing of yeasts | Q42057333 | ||
| Candida auris-associated candidemia, South Africa | Q42712931 | ||
| Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | Q43521723 | ||
| Candidemia caused by amphotericin B and fluconazole resistant Candida auris | Q44304263 | ||
| Shifting patterns in the epidemiology of nosocomial Candida infections | Q44436302 | ||
| National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. | Q54137486 | ||
| Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. | Q54198739 | ||
| International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group | Q73102772 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United Kingdom | Q145 |
| Candida auris | Q26816853 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | e00189-16 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | mSphere | Q27727104 |
| P1476 | title | Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species | |
| P478 | volume | 1 |
| Q40254903 | A Novel Restraint Device for Injection of Galleria mellonella Larvae that Minimizes the Risk of Accidental Operator Needle Stick Injury |
| Q90618019 | Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus |
| Q39092336 | Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. |
| Q42326663 | Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? |
| Q89754993 | Candida albicans increases the pathogenicity of Staphylococcus aureus during polymicrobial infection of Galleria mellonella larvae |
| Q92339644 | Candida auris Isolates of the Southern Asian and South African Lineages Exhibit Different Phenotypic and Antifungal Susceptibility Profiles In Vitro |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q89944189 | Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast |
| Q33704302 | Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally |
| Q48220845 | Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen |
| Q46255772 | Candida auris: An Emerging Fungal Pathogen |
| Q64068234 | Candida auris: An emerging pathogen "incognito"? |
| Q95642098 | Candida auris: From Multidrug Resistance to Pan-Resistant Strains |
| Q49988058 | Candida auris: a Review of the Literature. |
| Q39092282 | Candida auris: a worrisome, globally emerging pathogen |
| Q90610965 | Clade II Candida auris possess genomic structural variations related to an ancestral strain |
| Q100524782 | Clade-specific variation in susceptibility of Candida auris to broad-spectrum ultraviolet C light (UV-C) |
| Q92320618 | Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris |
| Q50128552 | Containment strategies to address the expanding threat of multidrug-resistant Candida auris |
| Q92479570 | Development of Candida auris Short Tandem Repeat Typing and Its Application to a Global Collection of Isolates |
| Q39375330 | Drugs currently under investigation for the treatment of invasive candidiasis |
| Q54957028 | Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. |
| Q58730092 | Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack |
| Q58598193 | Epidemiology, clinical characteristics, resistance, and treatment of infections by |
| Q93104959 | Experimental Mouse Models of Disseminated Candida auris Infection |
| Q59804393 | Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch |
| Q46257698 | Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses |
| Q39092120 | Fluconazole resistance in Candida species: a current perspective |
| Q110951300 | From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris |
| Q89355063 | From hidden outbreaks to epidemic emergencies: the threat associated with neglecting emerging pathogens |
| Q49679927 | Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All. |
| Q57793431 | Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris |
| Q93088245 | Identification of Drug Resistant Candida auris |
| Q92039317 | In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris |
| Q39092367 | Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016. |
| Q50985111 | Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. |
| Q37664411 | Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel |
| Q94464436 | Nine Things Genomics Can Tell Us About Candida auris |
| Q48316319 | Of mice and men and larvae: Galleria mellonella to model the early host-pathogen interactions after fungal infection. |
| Q58712631 | Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR |
| Q91728086 | Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae |
| Q64911580 | Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP). |
| Q39092215 | Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris |
| Q92071802 | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris |
| Q58761035 | Standardization of Larvae to Provide Reliable and Reproducible Results in the Study of Fungal Pathogens |
| Q38949297 | The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. |
| Q98771335 | The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris |
| Q58716618 | The Use of Larvae to Identify Novel Antimicrobial Agents against Fungal Species of Medical Interest |
| Q55312173 | The first isolate of Candida auris in China: clinical and biological aspects. |
| Q98665147 | Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris |
| Q55689919 | Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance. |
| Q89983562 | Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation |
| Q60958254 | What Have We Learned About Its Mechanisms of Pathogenicity? |
Search more.